DB01270 | Ranibizumab | approved | yes | antibody | Details |
DB01017 | Minocycline | approved, investigational | unknown | inhibitor | Details |
DB01120 | Gliclazide | approved | unknown | other/unknown | Details |
DB01136 | Carvedilol | approved, investigational | unknown | other | Details |
DB03088 | Pidolic acid | approved, investigational | unknown | | Details |
DB00112 | Bevacizumab | approved, investigational | yes | | Details |
DB04895 | Pegaptanib | approved, investigational | yes | antagonist | Details |
DB05294 | Vandetanib | approved | unknown | inhibitor | Details |
DB05434 | ABT-510 | investigational | unknown | | Details |
DB05890 | Veglin | investigational | unknown | | Details |
DB05932 | Denibulin | investigational | unknown | | Details |
DB05969 | SNS-032 | investigational | unknown | | Details |
DB06642 | Bevasiranib | investigational | unknown | | Details |
DB06779 | Dalteparin | approved | yes | inhibitor | Details |
DB08885 | Aflibercept | approved | yes | inhibitorbinder | Details |
DB09301 | Chondroitin sulfate | approved, investigational, nutraceutical | unknown | | Details |
DB10772 | Foreskin keratinocyte (neonatal) | approved | yes | agonist | Details |
DB14864 | Brolucizumab | approved, investigational | yes | inhibitor | Details |
DB15303 | Faricimab | approved, investigational | yes | antagonist | Details |
DB12317 | Vanucizumab | investigational | unknown | regulator | Details |